02:26
Thank you to the IBM Community
00:18
Orphazyme: Making an Impact on People With Rare Diseases
02:14
The Science of Heat Shock Proteins in Proteostasis
03:30
What is Niemann-Pick Disease Type C (NPC)?
14:44
Proteostasis: Heat Shock Proteins and Their Therapeutic Potential
X
About
Orphazyme is a late-stage biopharmaceutical company pioneering the heat shock protein response for the treatment of neurodegenerative orphan diseases.
Heat shock proteins (HSPs) are a group of endogenous stress-response proteins which protect against cellular toxicity caused by misfolded proteins, protein aggregation, and lysosomal dysfunction.
We encourage you to learn more about our science and our commitment to neurodegenerative orphan diseases at www.orphazyme.com/us. We also invite you to connect with us by signing up for email updates.
Tags